Wockhardt (NSE:WOCKPHARMA) Cyclically Adjusted PB Ratio: (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:WOCKPHARMA Wockhardt Ltd NSE:WOCKPHARMA
60 GF Score
Price ₹2,179.40
GF Value ₹1,466.35
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Wockhardt Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Wockhardt  (NSE:WOCKPHARMA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Wockhardt Cyclically Adjusted PB Ratio Related Terms


Wockhardt Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Wockhardt's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wockhardt Cyclically Adjusted PB Ratio Chart

Wockhardt Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.44 1.73 4.40 3.72

Wockhardt Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4.70 0.00 3.72 0.00

NSE:WOCKPHARMA vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Wockhardt's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wockhardt Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wockhardt's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Wockhardt's Cyclically Adjusted PB Ratio falls into.


NSE:WOCKPHARMA
60GF Score
Wockhardt Ltd NSE:WOCKPHARMA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wockhardt Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Wockhardt's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Wockhardt's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Wockhardt Quarterly Data

Book Value per Share CPI Adj_Book
201609 301.945 105.961 476.899
201612 0.000 105.196 0.000
201703 278.145 105.196 442.503
201706 0.000 107.109 0.000
201709 250.585 109.021 384.670
201712 0.000 109.404 0.000
201803 237.576 109.786 362.158
201806 0.000 111.317 0.000
201809 233.085 115.142 338.786
201812 0.000 115.142 0.000
201903 222.690 118.202 315.297
201906 0.000 120.880 0.000
201909 211.164 123.175 286.908
201912 0.000 126.235 0.000
202003 222.332 124.705 298.375
202006 0.000 127.000 0.000
202009 287.409 130.118 369.665
202012 0.000 130.889 0.000
202103 280.828 131.771 356.670
202106 0.000 134.084 0.000
202109 282.098 135.847 347.532
202112 0.000 138.161 0.000
202203 267.180 138.822 322.100
202206 0.000 142.347 0.000
202209 242.519 144.661 280.568
202212 0.000 145.763 0.000
202303 232.774 146.865 265.254
202306 0.000 150.280 0.000
202309 216.871 151.492 239.583
202312 0.000 152.924 0.000
202403 218.969 153.035 239.463
202406 0.000 155.789 0.000
202409 221.302 157.882 234.583
202412 0.000 158.323 0.000
202503 267.900 157.552 284.573
202506 0.000 159.755 0.000
202509 281.060 162.289 289.837
202512 0.000 163.281 0.000
202603 304.015 164.272 309.724
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Wockhardt (NSE:WOCKPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Wockhardt stock appears to be overvalued. The current stock price of ₹2,179.40 is trading 48.6% above its estimated GF Value™ of ₹1,466.35. GuruFocus considers Wockhardt to be Significantly Overvalued.

Key valuation signals for NSE:WOCKPHARMA:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹1,466.35 vs. price of ₹2,179.40 (48.6% above fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the NSE:WOCKPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wockhardt Business Description

Other Exchanges 532300:India
Address Bandra-Kurla Complex, Wockhardt Towers, Bandra East, Mumbai, MH, IND, 400051
Wockhardt Ltd is a drug manufacturing company focusing on pharmaceutical and biotechnology products. The group is involved in new drug discovery, contract manufacturing, API, vaccines, and branded pharmaceuticals business. In addition, it operates a chain of super-specialty hospitals. Its novel antibiotic platform has various assets, such as Zaynich (WCK 5222); Miqnaf (Nafithromycin), a macrolide-class respiratory antibiotic; Ertapenem-Zidebactam (WCK 6777); Foviscu (WCK 2482), an antibiotic for Gram-negative infections; and Odrate (WCK 6777), among others. The group is mainly engaged in the pharmaceutical business, which is considered its only reportable business segment. Geographically, it generates maximum revenue from Europe, followed by India, the USA, and the Rest of the world.
60GF Score

Get the complete analysis for NSE:WOCKPHARMA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,179.40
Price
₹1,466.35
GF Value